Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study.
Dattola A, Bernardini N, Svara F, Balato A, Caldarola G, D'Amico D, De Simone C, Di Brizzi EV, Esposito M, Giofrè C, Giordano D, Guarneri C, Loconsole F, Lora V, Moretta G, Orsini D, Persechino S, Potenza C, Ragonesi S, Pellacani G, Peris K, Fargnoli MC, Richetta AG. Dattola A, et al. Among authors: pellacani g. J Dermatolog Treat. 2024 Dec;35(1):2420825. doi: 10.1080/09546634.2024.2420825. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462515 Free article.
Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy.
Ardigò M, Bianchi L, Cantisani C, Cota C, DI Raimondo C, DI Stefani A, Fargnoli MC, Franceschini C, Pellacani G, Peris K, Persechino S, Plebani S, Potenza C, Proietti I, Quattrini L, Cantonetti M. Ardigò M, et al. Among authors: pellacani g. Ital J Dermatol Venerol. 2023 Apr;158(2):156-157. doi: 10.23736/S2784-8671.23.07377-2. Epub 2023 Mar 21. Ital J Dermatol Venerol. 2023. PMID: 36943388 No abstract available.
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
Fargnoli MC, Bardazzi F, Bianchi L, Dapavo P, Fabbrocini G, Gisondi P, Micali G, Offidani AM, Pellacani G, Skroza N, Angileri RG, Burlando M, Campanati A, Carrera CG, Chiricozzi A, Conti A, Simone C, Di Lernia V, Errichetti E, Galluzzo M, Guarneri C, Lasagni C, Lembo S, Loconsole F, Megna M, Musumeci ML, Prignano F, Richetta AG, Trovato E, Venturini M, Peris K, Pinton PC. Fargnoli MC, et al. Among authors: pellacani g. J Clin Med. 2023 May 18;12(10):3545. doi: 10.3390/jcm12103545. J Clin Med. 2023. PMID: 37240650 Free PMC article.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness.
Mannino M, Piccerillo A, Fabbrocini G, Quaglino P, Argenziano G, Dika E, Ascierto PA, Pellacani G, Longo C, Fargnoli MC, Bianchi L, Calzavara-Pinton P, Zalaudek I, Fava P, Scalvenzi M, Bocchino E, Di Stefani A, Peris K; and Collaborators. Mannino M, et al. Among authors: pellacani g. Dermatology. 2023;239(6):868-876. doi: 10.1159/000531280. Epub 2023 Jun 13. Dermatology. 2023. PMID: 37311439 Free article.
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.
Gori N, Sernicola A, Tolino E, Mariano M, Galluzzo M, Moretta G, Coppola R, D'Alessio A, Sansone M, Maffei V, Paolino C, Ferrao C, Cascia L, Addio P, Di Nardo L, Chiricozzi A, Del Duca E, Cristaudo A, Bianchi L, Pallotta S, Panasiti V, Pellacani G, Potenza C, Peris K. Gori N, et al. Among authors: pellacani g. J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685. J Dermatolog Treat. 2023. PMID: 37400981 Free article.
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).
Gargiulo L, Narcisi A, Ibba L, Balato A, Bianchi L, Brianti P, Buononato D, Burlando M, Caldarola G, Campanati A, Campione E, Carrera CG, Carugno A, Cristaudo A, Cusano F, Dapavo P, Dattola A, De Simone C, Gaiani FM, Gisondi P, Giunta A, Loconsole F, Maione V, Mortato E, Marzano AV, Maurelli M, Megna M, Mercuri SR, Offidani A, Orsini D, Parodi A, Pellacani G, Potestio L, Quaglino P, Richetta AG, Romano F, Sena P, Venturini M, Malagoli P, Costanzo A. Gargiulo L, et al. Among authors: pellacani g. Front Med (Lausanne). 2023 Aug 8;10:1243843. doi: 10.3389/fmed.2023.1243843. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614958 Free PMC article.
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, Bastholt L, Dreno B, Dummer R, Fargnoli MC, Forsea AM, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Lallas A, Leiter U, Malvehy J, Del Marmol V, Moreno-Ramirez D, Pellacani G, Peris K, Saiag P, Tagliaferri L, Trakatelli M, Ioannides D, Vieira R, Zalaudek I, Arenberger P, Eggermont AMM, Röcken M, Grob JJ, Lorigan P; EADO, EDF, ESTRO, UEMS, EADV and EORTC. Stratigos AJ, et al. Among authors: pellacani g. Eur J Cancer. 2023 Nov;193:113252. doi: 10.1016/j.ejca.2023.113252. Epub 2023 Jul 28. Eur J Cancer. 2023. PMID: 37708630 Free article.
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, Bastholt L, Dreno B, Dummer R, Fargnoli MC, Forsea AM, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Lallas A, Leiter U, Malvehy J, Del Marmol V, Moreno-Ramirez D, Pellacani G, Peris K, Saiag P, Tagliaferri L, Trakatelli M, Ioannides D, Vieira R, Zalaudek I, Arenberger P, Eggermont AMM, Röcken M, Grob JJ, Lorigan P; EADO, EDF, ESTRO, UEMS, EADV and EORTC. Stratigos AJ, et al. Among authors: pellacani g. Eur J Cancer. 2023 Nov;193:113251. doi: 10.1016/j.ejca.2023.113251. Epub 2023 Jul 28. Eur J Cancer. 2023. PMID: 37717283 Free article.
788 results